COPENHAGEN, Nov 2 (Reuters) – Bavarian Nordic has received a four-year contract from the British government for its vaccine against mpox and smallpox, the Danish vaccine maker said in a statement on Monday.
• Bavarian Nordic will supply its MVA-BN vaccine through scheduled deliveries
• The contract also includes optional flexibility provisions
• “It is vital to ensure that the UK has the right vaccines available to protect the public from a range of infectious disease threats,” the UK Health Security Agency said in the same statement
• Bavarian Nordic did not disclose the contract value
• Mpox is a viral disease that causes fever and skin lesions and spreads through close physical contact
(Reporting by Louise Rasmussen, editing by Stine Jacobsen)
